In Vivo CRISPR Gene Editing and Stem Cell Curative Horizons Defining Future Scope
The clinical development of in vivo stem cell gene editing platforms, novel red blood cell protection technologies, and early biomarker screening defines the future scope of the global Paroxysmal Nocturnal Hemoglobinuria Market. While current complement inhibitors manage disease symptoms indefinitely, emerging curative strategies aim to repair or bypass the underlying PIG-A gene mutation in...
0 Commentaires 0 Parts 170 Vue 0 Aperçu